Certara, Inc. filings document the public-company record for a Nasdaq-listed provider of biosimulation software and model-informed drug development services. Its 8-K reports include operating and financial results, guidance-related exhibits, material-event disclosures, credit agreement amendments and the completed sale of its global medical writing and related regulatory services business.
Proxy and governance filings describe annual-meeting matters, board composition, executive transitions and stockholder voting procedures. The record also identifies Certara's common stock, capital-structure disclosures and clinical or regulatory disclosures tied to software, services, regulatory science and clinical-development support.
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.15%
Tags
FAQ
How many Certara (CERT) SEC filings are available on StockTitan?
StockTitan tracks 61 SEC filings for Certara (CERT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Certara (CERT)?
The most recent SEC filing for Certara (CERT) was filed on November 5, 2026.